SLC2A1 and gestational diabetes: Gestational diabetes was induced by administering STZ at embryonic day 12.5 (E12.5), followed by treatment with the ferroptosis inhibitor Lip1 or the GLUT1 inhibitor WZB117 on alternate days from E13.5 to E18.5 (Fig. 5A).